<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · Novartis Pharma</title><link>https://yestino.com/entities/novartis-pharma-8201a3</link><description>Every event involving Novartis Pharma</description><language>en</language><atom:link href="https://yestino.com/entities/novartis-pharma-8201a3/feed.xml" rel="self" type="application/rss+xml"/><item><title>BoomRay and Novartis Pharma sign $900m deal for radioligand therapy</title><link>https://yestino.com/events/boomray-and-novartis-pharma-sign-900m-deal-for-radioligand-t-cb96bd</link><guid isPermaLink="true">https://yestino.com/events/boomray-and-novartis-pharma-sign-900m-deal-for-radioligand-t-cb96bd</guid><pubDate>Wed, 23 Sep 2026 10:18:31 GMT</pubDate><description>Sources: Yahoo Finance</description></item></channel></rss>